CD4 and myeloid sarcoma: We next set out to verify whether these genetic influences on ANKRD55 and IL6ST gene expression are measurable in CD4+ T lymphocytes and immature moDCs derived from CD14+ monocytes freshly isolated from venous blood samples from untreated MS patients (clinical and demographic data of MS patients in Supplementary Table S1).